|LTUS -- USA Stock|| |
USD 0.005 0.001 16.67%
Dr. Xing Shen, Ph.D., is Vice President Corporationrationrate Development of Lotus Pharmaceuticals, Inc. He was with the Company since July 2009. From July 2006 through May 2009, Mr. Shen was an associate equity analyst for RBC Capital Markets, where he cocovered approximately 30 companies in the biotech industry. Mr. Shen received a Masters of Business Administration in 2006 and a Doctorate in Molecular Cancer Biology in 2000 from Duke University. Mr. Shen received a MS in plant molecular biology from Peking University in 1995 and a BS in Virology from Wuhan University in 1992
Age: 39 VP Since 2010 CFA
86 10 6389 9868 http://www.lotuspharma.com
Shen has received Series 7, 63, 86 and 87 licenses from Finra and is a Chartered Financial Analyst level one candidate.